Literature DB >> 21873427

Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.

Jason A Lehman1, David L Waning, Christopher N Batuello, Rocky Cipriano, Madhavi P Kadakia, Lindsey D Mayo.   

Abstract

The p53 family member, p73, has been characterized as a tumor suppressor and functions in a similar manner as p53 to induce cellular death. The phosphatase and tensin homolog (PTEN) can function as a dual specificity lipid/protein phosphatase. However, recent data have described multiple roles for nuclear PTEN independent of its lipid phosphatase activity. PTEN can directly or indirectly activate p53 to promote apoptosis. We examined whether PTEN would interact and regulate p73 independent of p53. Co-localization in the nucleus and complex formation of p73/PTEN were observed after DNA damage. Furthermore, we also demonstrate that p73α/PTEN proteins directly bind one another. Both overexpressed and endogenous p73-PTEN interactions were determined to be the strongest in the nuclear fraction after DNA damage, which suggested formation of a transcriptional complex. We employed chromatin immunoprecipitation (ChIP) and found that p73 and PTEN were associated with the PUMA promoter after genotoxic stress in TP53-null cells. We found that another p73 target, BAX, had an increased expression in the presence of p73 and PTEN. In addition, in virus-transduced cell lines stably expressing p73, PTEN, or both p73/PTEN, we found that the p73/PTEN cells were more sensitive to genotoxic stress and cellular death as measured by increased poly(ADP-ribose) polymerase cleavage and PUMA/Bax induction. Conversely, knockdown of PTEN dramatically reduced Bax and PUMA levels. Thus, a p73-PTEN protein complex is engaged to induce apoptosis independent of p53 in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873427      PMCID: PMC3196149          DOI: 10.1074/jbc.M110.217620

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Authors:  Elsa R Flores; Kenneth Y Tsai; Denise Crowley; Shomit Sengupta; Annie Yang; Frank McKeon; Tyler Jacks
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  Viral oncoproteins discriminate between p53 and the p53 homolog p73.

Authors:  M C Marin; C A Jost; M S Irwin; J A DeCaprio; D Caput; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

3.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.

Authors:  Veronica Vella; Cinzia Puppin; Giuseppe Damante; Riccardo Vigneri; Mariangela Sanfilippo; Paolo Vigneri; Gianluca Tell; Francesco Frasca
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

6.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

7.  Controlling the Mdm2-Mdmx-p53 Circuit.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

Review 8.  Understanding PTEN regulation: PIP2, polarity and protein stability.

Authors:  N R Leslie; I H Batty; H Maccario; L Davidson; C P Downes
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

9.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Authors:  M P Myers; I Pass; I H Batty; J Van der Kaay; J P Stolarov; B A Hemmings; M H Wigler; C P Downes; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

View more
  12 in total

1.  Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells.

Authors:  Rasmi Rekha Mishra; Jitendra Kumar Chaudhary; Pramod C Rath
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

Review 2.  PTEN at a glance.

Authors:  Yuji Shi; Benjamin E Paluch; Xinjiang Wang; Xuejun Jiang
Journal:  J Cell Sci       Date:  2012-10-15       Impact factor: 5.285

Review 3.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 4.  Cell Cycle Control by PTEN.

Authors:  Andrew Brandmaier; Sheng-Qi Hou; Wen H Shen
Journal:  J Mol Biol       Date:  2017-06-09       Impact factor: 5.469

5.  Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.

Authors:  Weicheng Ren; Xiaofei Ye; Hong Su; Wei Li; Dongbing Liu; Mohammad Pirmoradian; Xianhuo Wang; Bo Zhang; Qiang Zhang; Longyun Chen; Man Nie; Yao Liu; Bin Meng; Huiqiang Huang; Wenqi Jiang; Yixin Zeng; Wenyu Li; Kui Wu; Yong Hou; Klas G Wiman; Zhiming Li; Huilai Zhang; Roujun Peng; Shida Zhu; Qiang Pan-Hammarström
Journal:  Blood       Date:  2018-03-15       Impact factor: 22.113

6.  Tumor suppressors: enhancers or suppressors of regeneration?

Authors:  Jason H Pomerantz; Helen M Blau
Journal:  Development       Date:  2013-06       Impact factor: 6.868

7.  Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK.

Authors:  Eric R Wolf; Ciarán P McAtarsney; Kristin E Bredhold; Amber M Kline; Lindsey D Mayo
Journal:  Sci Signal       Date:  2018-04-03       Impact factor: 8.192

8.  A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells.

Authors:  Rasmi Rekha Mishra; Jitendra Kumar Chaudhary; Gagan Deep Bajaj; Pramod C Rath
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

9.  Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.

Authors:  Stéphane Collaud; Verena Tischler; Andrej Atanassoff; Thomas Wiedl; Paul Komminoth; Christian Oehlschlegel; Walter Weder; Alex Soltermann
Journal:  BMC Cancer       Date:  2015-02-20       Impact factor: 4.430

10.  Serdemetan antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes.

Authors:  Jason A Lehman; Paula M Hauck; Jaimie M Gendron; Christopher N Batuello; Jacob A Eitel; Allan Albig; Madhavi P Kadakia; Lindsey D Mayo
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.